142 related articles for article (PubMed ID: 25218956)
1. Contraceptive continuation in Hispanic women.
Werth SR; Secura GM; Broughton HO; Jones ME; Dickey V; Peipert JF
Am J Obstet Gynecol; 2015 Mar; 212(3):312.e1-8. PubMed ID: 25218956
[TBL] [Abstract][Full Text] [Related]
2. Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project.
Allsworth JE; Secura GM; Ajibade OO; Peipert JF
J Womens Health (Larchmt); 2018 May; 27(5):599-606. PubMed ID: 29768114
[TBL] [Abstract][Full Text] [Related]
3. Three-year continuation of reversible contraception.
Diedrich JT; Zhao Q; Madden T; Secura GM; Peipert JF
Am J Obstet Gynecol; 2015 Nov; 213(5):662.e1-8. PubMed ID: 26259905
[TBL] [Abstract][Full Text] [Related]
4. Continuation and satisfaction of reversible contraception.
Peipert JF; Zhao Q; Allsworth JE; Petrosky E; Madden T; Eisenberg D; Secura G
Obstet Gynecol; 2011 May; 117(5):1105-1113. PubMed ID: 21508749
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four-month continuation of reversible contraception.
O'Neil-Callahan M; Peipert JF; Zhao Q; Madden T; Secura G
Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781
[TBL] [Abstract][Full Text] [Related]
6. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
7. Continuation of reversible contraception in teenagers and young women.
Rosenstock JR; Peipert JF; Madden T; Zhao Q; Secura GM
Obstet Gynecol; 2012 Dec; 120(6):1298-305. PubMed ID: 23168753
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with postpartum use of long-acting reversible contraception.
Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
[TBL] [Abstract][Full Text] [Related]
9. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
10. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants.
Simmons RG; Sanders JN; Geist C; Gawron L; Myers K; Turok DK
Am J Obstet Gynecol; 2019 Apr; 220(4):376.e1-376.e12. PubMed ID: 30576664
[TBL] [Abstract][Full Text] [Related]
11. Twelve-month contraceptive continuation among women initiating short- and long-acting reversible contraceptives in North Kivu, Democratic Republic of the Congo.
Casey SE; Cannon A; Mushagalusa Balikubirhi B; Muyisa JB; Amsalu R; Tsolka M
PLoS One; 2017; 12(9):e0182744. PubMed ID: 28886016
[TBL] [Abstract][Full Text] [Related]
12. Impact of a theory-based video on initiation of long-acting reversible contraception after abortion.
Davidson AS; Whitaker AK; Martins SL; Hill B; Kuhn C; Hagbom-Ma C; Gilliam M
Am J Obstet Gynecol; 2015 Mar; 212(3):310.e1-7. PubMed ID: 25265403
[TBL] [Abstract][Full Text] [Related]
13. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
Paul R; Huysman BC; Maddipati R; Madden T
Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
[TBL] [Abstract][Full Text] [Related]
14. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
Hubacher D; Spector H; Monteith C; Chen PL
Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of women in the United States who use long-acting reversible contraceptive methods.
Kavanaugh ML; Jerman J; Hubacher D; Kost K; Finer LB
Obstet Gynecol; 2011 Jun; 117(6):1349-1357. PubMed ID: 21606745
[TBL] [Abstract][Full Text] [Related]
16. Satisfaction, early removal, and side effects associated with long-acting reversible contraception.
Dickerson LM; Diaz VA; Jordon J; Davis E; Chirina S; Goddard JA; Carr KB; Carek PJ
Fam Med; 2013; 45(10):701-7. PubMed ID: 24347187
[TBL] [Abstract][Full Text] [Related]
17. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
Fleming D; Davie J; Glasier A
Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
[TBL] [Abstract][Full Text] [Related]
18. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
[TBL] [Abstract][Full Text] [Related]
19. Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database.
Agostini A; Godard C; Laurendeau C; Benmahmoud Zoubir A; Lafuma A; Lévy-Bachelot L; Gourmelen J; Linet T
Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):421-426. PubMed ID: 30499732
[TBL] [Abstract][Full Text] [Related]
20. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.
Chappell CA; Harkoo I; Szydlo DW; Bunge KE; Singh D; Nakabiito C; Mhlanga F; Kamira B; Piper JM; Balkus JE; Hillier SL;
Contraception; 2019 Sep; 100(3):214-218. PubMed ID: 31226323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
